Filing Details

Accession Number:
0001209191-12-024645
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-27 16:30:29
Reporting Period:
2012-04-26
Filing Date:
2012-04-27
Accepted Time:
2012-04-27 16:30:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235118 S Randall Livingston Stanford University
Bldg 60, Main Quadrangle
Stanford CA 94305
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-26 2,000 $1.33 8,149 No 4 M Direct
Common Stock Disposition 2012-04-26 2,000 $28.21 6,149 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-04-26 2,000 $0.00 2,000 $1.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,346 2014-10-06 No 4 M Direct
Footnotes
  1. This sale of common stock was effected persuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 18, 2011.
  2. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  3. Represents weighted average sale price. Actual sale prices ranged from $28.05 to $28.42.
  4. The option became exercisable as to 25% of the shares on October 6, 2005,and became exercisable as to 1/48th of the shares each full month thereafter.